YorkBridge Wealth Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-812
Closed -$136K 745
2019
Q2
$136K Buy
812
+104
+15% +$14.4K 0.06% 243
2019
Q1
$104K Buy
708
+69
+11% +$10K 0.05% 270
2018
Q4
$85K Sell
639
-618
-49% -$101K 0.05% 271
2018
Q3
$242K Sell
1,257
-1,177
-48% -$216K 0.11% 151
2018
Q2
$406K Sell
2,434
-210
-8% -$33.7K 0.18% 117
2018
Q1
$440K Buy
2,644
+81
+3% +$13.6K 0.2% 104
2017
Q4
$423K Sell
2,563
-1,137
-31% -$204K 0.2% 108
2017
Q3
$758K Sell
3,700
-536
-13% -$125K 0.39% 64
2017
Q2
$1.03M Sell
4,236
-74
-2% -$17.4K 0.55% 51
2017
Q1
$1.06M Sell
4,310
-453
-10% -$105K 0.55% 49
2016
Q4
$916K Buy
+4,763
New +$987K 0.54% 52

Other funds holding AGN

YorkBridge Wealth Partners's AGN Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 812 shares — an estimated $136K sold.

YorkBridge Wealth Partners first reported a position in AGN in Q4 2016 and held it in 11 quarters. The position peaked at $1.06M in Q1 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • YorkBridge Wealth Partners reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 812 Allergan plc shares in Q3 2019, an estimated $136K.
  • YorkBridge Wealth Partners first reported a position in Allergan plc in Q4 2016 and held it in 11 quarters.
  • YorkBridge Wealth Partners's Allergan plc position peaked at $1.06M in Q1 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.